Open access
Open access
Powered by Google Translator Translator

FDA Safety Communication: Gabapentinoids may Cause Serious Respiratory Problems in Predisposed Patients

8 Jan, 2020 | 01:10h | UTC

FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) – U.S Food & Drug Administration (free)

See also: Neurontin, Gralise, Horizant (gabapentin) and Lyrica, Lyrica CR (pregabalin): Drug Safety Communication – Serious Breathing Problems – U.S Food & Drug Administration (free)

Commentaries: Gabapentinoids Linked to Respiratory Problems in Certain Patients – NEJM Journal Watch (free) AND FDA warns gabapentin, pregabalin may cause serious breathing problems – The Hospitalist (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.